Connect with us:   Email This Page  | Print
The information on this site is designed for patients. If you are a healthcare professional, click here.
Learn more about Neuronetics, developer of the NeuroStar TMS Therapy System.
NeuroStar TMS Therapy® is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from one prior antidepressant medication at or above the minimal effective dose and duration in the current episode. Click here for full prescribing and safety information
Find a Provider

For decades, researchers have sought safe and effective treatments for depression. However, there is no single depression treatment which has been proven to work for everyone.

Depression is often treated with antidepressants medications; however, alternative treatments for depression are available. These depression therapies have been shown to work in people who do not receive benefit from medications. Such patients may also be unable to tolerate the side effects caused by them. One alternative therapy for the treatment of depression is transcranial magnetic stimulation. NeuroStar TMS (transcranial magnetic stimulation) Therapy is FDA-cleared for patients suffering from depression who have not achieved satisfactory improvement from prior antidepressant medications*.

Transcranial Magnetic Stimulation (TMS)
Transcranial magnetic stimulation therapy uses short pulses of magnetic fields to stimulate nerve cells in the area of the brain thought to control mood. It is sometimes referred to as rTMS which stands for repetitive transcranial magnetic stimulation. TMS Therapy is performed in a psychiatrist’s office under their supervision while the patient remains awake and alert.

NeuroStar TMS Therapy® is an outpatient procedure. The typical treatment course consists of 5 treatments per week over a 4-6 week period for 20-30 treatments. Each depression treatment session lasts approximately 37 minutes. NeuroStar TMS Therapy is:

  • Non-invasive, meaning that it does not involve surgery. It does not require any anesthesia or sedation, as the patient remains awake and alert during the treatment.
  • Non-systemic, meaning that it is not taken by mouth and does not circulate in the bloodstream throughout the body.
  • FDA cleared for patients who have not benefited from prior antidepressant treatment.*

Click here for full safety and prescribing information


Copyright © 2012 Neuronetics. All Rights Reserved Sitemap  | Privacy Policy  | Terms and Conditions  | Glossary

This link provides you with access to recent published information and news about NeuroStar TMS Therapy and new options for the treatment of depression. Neuronetics does not provide any assurances of the accuracy of this information and may not agree with the opinions of the authors.

NeuroStar TMS Therapy is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from one prior antidepressant medication at or above the minimal effective dose and duration in the current episode. To return to the Neuronetics website for full safety and prescribing information click here.

Click here to continue.